Forbion Growth Opportunities Fund I Cooperatief U.A. (CIK 0001911047)

Latest company ownership

NAMSW - NewAmsterdam Pharma Co N.V.

Role: 10% Owner

Shares held

10,656,172

Last filed at

Jan 2, 2025

Confidence Score

49.9

2025Q4

Confidence Score History

2024Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 30, 2024	Jan 2, 2025	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	46.3	-29,846	-0.28%	✓	$762.2K
Dec 26, 2024	Dec 30, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	42.5	-74,910	-0.70%	✓	$1.9M
Dec 20, 2024	Dec 26, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	42.5	-91,068	-0.84%	✓	$2.3M
Dec 18, 2024	Dec 20, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	40.0	-157,234	-1.43%	✓	$4.1M
Dec 16, 2024	Dec 18, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	40.0	-115,480	-1.04%	✓	$3M
Dec 12, 2024	Dec 16, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	40.0	-191,762	-1.69%	✓	$4.9M
Dec 10, 2024	Dec 12, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	30.0	-462,288	-3.92%	✓	$11.7M
Nov 15, 2024	Nov 19, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	43.8	-41,803	-0.35%	✓	$1M
Nov 13, 2024	Nov 15, 2024	NewAmsterdam Pharma Co N.V.	10% Owner	Sell	48.8	-10,898	-0.09%	✓	$272.5K
Oct 30, 2024	Nov 1, 2024	enGene Holdings Inc.	10% Owner	Buy	95.0	+561,797	9.01%	✗	$5M
Dec 27, 2023	Oct 18, 2024	enGene Holdings Inc.	10% Owner	Buy	95.0	+470,633	8.16%	✗	$3M